Joanne Otani

538 total citations
17 papers, 396 citations indexed

About

Joanne Otani is a scholar working on Hematology, Immunology and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Joanne Otani has authored 17 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 6 papers in Immunology and 5 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Joanne Otani's work include Hematopoietic Stem Cell Transplantation (5 papers), Chronic Myeloid Leukemia Treatments (5 papers) and T-cell and B-cell Immunology (4 papers). Joanne Otani is often cited by papers focused on Hematopoietic Stem Cell Transplantation (5 papers), Chronic Myeloid Leukemia Treatments (5 papers) and T-cell and B-cell Immunology (4 papers). Joanne Otani collaborates with scholars based in United States. Joanne Otani's co-authors include Dennis J. Paustenbach, Brent L. Finley, Brooke E. Tvermoes, Kenneth M. Unice, David A. Galbraith, Deborah M. Proctor, Edward V. Sargent, David B. Miklos, Mark Anglin Harris and Bita Sahaf and has published in prestigious journals such as Blood, American Journal of Clinical Nutrition and Food and Chemical Toxicology.

In The Last Decade

Joanne Otani

16 papers receiving 378 citations

Peers

Joanne Otani

HTM

HEMAT

IMMUN

POLLU

Maryse Lemaire Canada

Mauro Valeri Italy

Anne Johansson Sweden

Manman Shi China

Yuxing Hu China

Cécile Michel France

Shigeharu Miwa Japan

Barbara Baluce Italy

Roland Schindl Germany

Jianzhi Sun China

Maryse Lemaire Canada

Joanne Otani

170 ×1.1

HTM

47 ×0.5

HEMAT

55 ×0.8

IMMUN

43 ×1.0

POLLU

92 ×2.1

Citations per year, relative to Joanne Otani Joanne Otani (= 1×) peers Maryse Lemaire

Countries citing papers authored by Joanne Otani

Since Specialization

Citations

This map shows the geographic impact of Joanne Otani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanne Otani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanne Otani more than expected).

Fields of papers citing papers by Joanne Otani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanne Otani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanne Otani. The network helps show where Joanne Otani may publish in the future.

Co-authorship network of co-authors of Joanne Otani

This figure shows the co-authorship network connecting the top 25 collaborators of Joanne Otani. A scholar is included among the top collaborators of Joanne Otani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanne Otani. Joanne Otani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Chen, George L., Paul A. Carpenter, Raewyn Broady, et al.. (2017). Anti–Platelet-Derived Growth Factor Receptor Alpha Chain Antibodies Predict for Response to Nilotinib in Steroid-Refractory or -Dependent Chronic Graft-Versus-Host Disease. Biology of Blood and Marrow Transplantation. 24(2). 373–380. 10 indexed citations

Johnston, Laura, Randall Armstrong, Jeanette Baker, et al.. (2016). A Phase I Study of Donor Regulatory T Cells As Treatment for Steroid Dependent/Refractory Chronic Graft Versus Host Disease. Blood. 128(22). 385–385. 7 indexed citations

Nakasone, Hideki, Lü Tian, Bita Sahaf, et al.. (2015). Allogeneic HY antibodies detected 3 months after female-to-male HCT predict chronic GVHD and nonrelapse mortality in humans. Blood. 125(20). 3193–3201. 47 indexed citations

Ryan, Christine E., Aaron C. Logan, Andrew R. Rezvani, et al.. (2015). Ibrutinib Treatment of Relapsed CLL Following Allogeneic Transplantation: Sustained Disease Response and Promising Donor Immune Modulation. Biology of Blood and Marrow Transplantation. 21(2). S307–S308. 2 indexed citations

Tvermoes, Brooke E., Kenneth M. Unice, Dennis J. Paustenbach, et al.. (2014). Effects and blood concentrations of cobalt after ingestion of 1 mg/d by human volunteers for 90 d. American Journal of Clinical Nutrition. 99(3). 632–646. 48 indexed citations

Ryan, Christine E., Aaron C. Logan, Andrew R. Rezvani, et al.. (2014). Ibrutinib Treatment of Relapsed CLL Following Allogeneic Transplantation: Sustained Disease Response and Promising Donor Immune Modulation. Blood. 124(21). 1186–1186. 5 indexed citations

Finley, Brent L., Kenneth M. Unice, Brent D. Kerger, et al.. (2013). 31-Day Study of Cobalt(II) Chloride Ingestion in Humans: Pharmacokinetics and Clinical Effects. Journal of Toxicology and Environmental Health. 76(21). 1210–1224. 30 indexed citations

Nakasone, Hideki, Lü Tian, Takakazu Kawase, et al.. (2013). Allogeneic HY Antibodies 3 Months Following Sex-Mismatched HCT Predicts Chronic Graft-Versus-Host Disease and Non-Relapse Mortality. Blood. 122(21). 147–147. 2 indexed citations

Sahaf, Bita, et al.. (2013). Rituximab Provides Steroid-Sparing Therapy in New-Onset Chronic Graft-Versus-Host Disease. Biology of Blood and Marrow Transplantation. 19(2). S140–S140. 7 indexed citations

10.

Tvermoes, Brooke E., Brent L. Finley, Kenneth M. Unice, et al.. (2012). Cobalt whole blood concentrations in healthy adult male volunteers following two-weeks of ingesting a cobalt supplement. Food and Chemical Toxicology. 53. 432–439. 48 indexed citations

11.

Chen, George L., Sally Arai, Mary E.D. Flowers, et al.. (2011). A phase 1 study of imatinib for corticosteroid-dependent/refractory chronic graft-versus-host disease: response does not correlate with anti-PDGFRA antibodies. Blood. 118(15). 4070–4078. 27 indexed citations

12.

Chen, George L., Sally Arai, Mary E.D. Flowers, et al.. (2009). A Dose Escalation Trial of Imatinib for Steroid Dependent Chronic Graft-Versus-Host Disease with Anti-PDGFRA Antibody Analysis.. Blood. 114(22). 3304–3304. 1 indexed citations

13.

Proctor, Deborah M., et al.. (2002). IS HEXAVALENT CHROMIUM CARCINOGENIC VIA INGESTION? A WEIGHT-OF-EVIDENCE REVIEW. Journal of Toxicology and Environmental Health. 65(10). 701–746. 103 indexed citations

14.

Panko, Julie M., et al.. (2002). 29. Retrospective Exposure Assessment for Painesville, Ohio Chromate Production Workers (1940–1972). AIHce 2002. 29–29.

15.

Fowler, Joseph F., C. Lisa Kauffman, James G. Marks, et al.. (1999). An Environmental Hazard Assessment of Low-Level Dermal Exposure to Hexavalent Chromium in Solution Among Chromium-Sensitized Volunteers. Journal of Occupational and Environmental Medicine. 41(3). 150–160. 14 indexed citations

16.

Otani, Joanne, et al.. (1994). Use of Probabilistic Methods to Understand the Conservatism in California’s Approach to Assessing Health Risks Posed by Air Contaminants. PubMed. 44(12). 1399–1413. 17 indexed citations

17.

Paustenbach, Dennis J., et al.. (1993). Comparing the Results of a Monte Carlo Analysis with EPA′s Reasonable Maximum Exposed Individual (RMEI): A Case Study of a Former Wood Treatment Site. Regulatory Toxicology and Pharmacology. 18(2). 275–312. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact